Literature DB >> 12791138

The kinetic properties of the carboxy terminal domain of the Bacillus licheniformis 749/I BlaR penicillin-receptor shed a new light on the derepression of beta-lactamase synthesis.

Valérie Duval1, Marc Swinnen, Sophie Lepage, Alain Brans, Benoît Granier, Christine Franssen, Jean-Marie Frère, Bernard Joris.   

Abstract

To study the properties of the BlaR penicillin-receptor involved in the induction of the Bacillus licheniformisbeta-lactamase, the water-soluble carboxy terminal domain of the protein (BlaR-CTD) was overproduced in the periplasm of Escherichia coli JM105 and purified to protein homogeneity. Its interactions with various beta-lactam antibiotics were studied. The second-order acylation rate constants k2/K' ranged from 0.0017 to more than 1 micro M-1s-1 and the deacylation rate constants were lower than 4 x 10-5 s-1. These values imply a rapid to very rapid formation of a stable acylated adduct. BlaR-CTD is thus one of the most sensitive penicillin-binding proteins presently described. In the light of these results, the kinetics of beta-lactamase induction in Bacillus licheniformis were re-examined. When starting with a rather high cell density, a good beta-lactamase substrate such as benzylpenicillin is too sensitive to beta-lactamase-mediated hydrolysis to allow full induction. By contrast, a poor beta-lactamase substrate (7-aminocephalosporanic acid) can fully derepress beta-lactamase expression under conditions where interference of the antibiotic with cell growth is observed. These results suggest that acylation of the penicillin receptor is a necessary, but not sufficient, condition for full induction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791138     DOI: 10.1046/j.1365-2958.2003.03520.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  7 in total

1.  Guanidinium chloride denaturation of the dimeric Bacillus licheniformis BlaI repressor highlights an independent domain unfolding pathway.

Authors:  Christelle Vreuls; Patrice Filée; Hélène Van Melckebeke; Tony Aerts; Peter De Deyn; Gabriel Llabrès; André Matagne; Jean-Pierre Simorre; Jean-Marie Frère; Bernard Joris
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

2.  Structure-function studies of the staphylococcal methicillin resistance antirepressor MecR2.

Authors:  Pedro Arêde; Tiago Botelho; Tibisay Guevara; Isabel Usón; Duarte C Oliveira; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

3.  The ybxI gene of Bacillus subtilis 168 encodes a class D beta-lactamase of low activity.

Authors:  Maria-Luigi Colombo; Sophie Hanique; Stéphane L Baurin; Cédric Bauvois; Kris De Vriendt; Jozef J Van Beeumen; Jean-Marie Frère; Bernard Joris
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

4.  A peptidoglycan fragment triggers β-lactam resistance in Bacillus licheniformis.

Authors:  Ana Amoroso; Julien Boudet; Stéphanie Berzigotti; Valérie Duval; Nathalie Teller; Dominique Mengin-Lecreulx; André Luxen; Jean-Pierre Simorre; Bernard Joris
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

5.  Bacillus licheniformis BlaR1 L3 loop is a zinc metalloprotease activated by self-proteolysis.

Authors:  Stéphanie Berzigotti; Kamal Benlafya; Jérémy Sépulchre; Ana Amoroso; Bernard Joris
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 6.  The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.

Authors:  Dalal Hammoudi Halat; Carole Ayoub Moubareck
Journal:  Antibiotics (Basel)       Date:  2020-04-16

7.  Construction of an Electrochemical Receptor Sensor Based on Graphene/Thionine for the Sensitive Determination of β-Lactam Antibiotics Content in Milk.

Authors:  Lei Wang; Liyun Zhang; Yuke Wang; Yahong Ou; Xu Wang; Yuanhu Pan; Yulian Wang; Lingli Huang; Guyue Cheng; Shuyu Xie; Dongmei Chen; Yanfei Tao
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.